Trial Profile
A Phase II Study of Carboplatin, Nab-paclitaxel and Cetuximab for Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Carboplatin (Primary) ; Cetuximab (Primary) ; Paclitaxel (Primary)
- Indications Head and neck cancer; Squamous cell cancer
- Focus Therapeutic Use
- 03 Nov 2020 Status changed from active, no longer recruiting to completed.
- 25 Mar 2020 Planned End Date changed from 1 Apr 2020 to 1 Apr 2021.
- 30 Jun 2017 Planned End Date changed from 1 Feb 2018 to 1 Apr 2020.